Check-Cap (CHEK) Stock Price, News & Analysis

Company Overview

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Key Stats

• Today's Range: $0.65 to $0.92
• 50-Day Range: $0.65 to $1.05
• 52-Week Range: $0.56 to $3.04
• Volume: 420,850 shs
• Average Volume: 367,478 shs
• Market Capitalization: $4.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Check-Cap Stock Analysis - MarketRank™

Check-Cap scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Check-Cap.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Check-Cap is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Check-Cap is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Check-Cap has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.27% of the float of Check-Cap has been sold short.

Short Interest Ratio / Days to Cover

Check-Cap has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Check-Cap has recently decreased by 40.15%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Check-Cap does not currently pay a dividend.

Dividend Growth

Check-Cap does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.27% of the float of Check-Cap has been sold short.

Short Interest Ratio / Days to Cover

Check-Cap has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Check-Cap has recently decreased by 40.15%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.72

News Sentiment

Check-Cap has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Check-Cap this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for CHEK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Check-Cap insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.48% of the stock of Check-Cap is held by insiders.

Percentage Held by Institutions

Only 1.07% of the stock of Check-Cap is held by institutions.

CHEK Stock Analysis - Frequently Asked Questions

How have CHEK shares performed this year?

Check-Cap's stock was trading at $0.9899 at the start of the year. Since then, CHEK shares have decreased by 20.2% and is now trading at $0.79.
View the best growth stocks for 2025 here.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) posted its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.83) by $0.39.

When did Check-Cap's stock split?

Shares of Check-Cap reverse split on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Check-Cap IPO?

Check-Cap (CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Check-Cap own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Check-Cap investors own include NVIDIA (NVDA), PayPal (PYPL), Meta Platforms (META), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA).

Company Calendar

• Last Earnings: 11/27/2023
• Today: 4/27/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: X - ray apparatus & tubes
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:CHEK
• CIK: 1610590
• Web: www.check-cap.com
• Phone: 972546706451
• Fax: 972-4821-1267
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 19.67
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.05 per share
• Price / Book: 0.20

Miscellaneous

• Outstanding Shares: 5,851,000
• Free Float: 5,823,000
• Market Cap: $4.62 million
• Optionable: Not Optionable
• Beta: 0.20